Evoke Pharma Inc. buy DomRuinart
Start price
18.11.20
/
50%
€32.66
Target price
18.11.21
€60.00
Performance (%)
-3.60%
End price
30.11.20
€31.49
Summary
This prediction ended on 30.11.20 with a price of €31.49. With a performance of -3.60%, the BUY prediction by DomRuinart finished with a loss. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evoke Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
According to DomRuinart what are the pros and cons of Evoke Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Evoke Pharma Inc. diskutieren
Buy mit Kursziel 5,0
In the thread Trading Evoke Pharma Inc.
Buy beendet


